05:03:44 EDT Fri 23 Apr 2021
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Oncolytics Biotech Inc (2)
Symbol ONC
Shares Issued 47,688,081
Close 2021-02-25 C$ 4.36
Recent Sedar Documents

Oncolytics to hold 2020 financial call on March 5

2021-02-26 07:46 ET - News Release

Mr. Kirk Look reports

ONCOLYTICS BIOTECH TO HOST CONFERENCE CALL TO DISCUSS FOURTH QUARTER AND FULL YEAR FINANCIAL RESULTS AND OPERATIONAL HIGHLIGHTS

Oncolytics Biotech Inc. will host a conference call and webcast on Friday, March 5, 2021, at 8:30 a.m. ET to discuss a corporate update and financial results for the fourth quarter and full year 2020.

Conference call and webcast

Date:  Friday, March 5, 2021

Time:  8:30 a.m. ET

Dial-in number -- North American toll-free:  888-231-8191

Dial-in number -- international:  647-427-7450

Conference ID (if needed):  569-6653

Webcast:  available on-line

A live webcast of the call will also be available on the investor relations page of Oncolytics's website and will be archived for three months. A dial-in replay will be available for one week and can be accessed by dialling 855-859-2056 (North America) or 416-849-0833 (international) and using reference code 569-6653.

About Oncolytics Biotech Inc.

Oncolytics is a biotechnology company developing pelareorep, an intravenously delivered immuno-oncolytic virus. The compound induces selective tumour lysis and promotes an inflamed tumour phenotype -- turning cold tumours hot -- through innate and adaptive immune responses to treat a variety of cancers.

We seek Safe Harbor.

© 2021 Canjex Publishing Ltd. All rights reserved.